SPDR® MSCI Europe Health Care UCITS ETF | STWRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 3.5 | 17.6 | 1.0 | 5.9 | 6.6 | |
+/-Cat | -14.0 | 8.1 | 5.6 | 9.0 | 1.3 | |
+/-B’mrk | - | -0.7 | -4.9 | 8.4 | -1.5 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 29/04/2024 | EUR 219.25 | |
Day Change | 0.08% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 721 | |
Exchange | EURONEXT PARIS S.A. | |
ISIN | IE00BKWQ0H23 | |
Fund Size (Mil) 29/04/2024 | EUR 653.79 | |
Share Class Size (Mil) 29/04/2024 | EUR 653.79 | |
Ongoing Charge 27/10/2023 | 0.18% |
Investment Objective: SPDR® MSCI Europe Health Care UCITS ETF | STW |
The investment objective of the Fund is to track the performance of European large and midsized companies in the Health Care sector. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Ludovic Brancourt 05/12/2014 | ||
Inception Date 05/12/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Health Care 35/20 Capped NR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for SPDR® MSCI Europe Health Care UCITS ETF | STW | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 24.38 |
AstraZeneca PLC | Healthcare | 12.24 |
Novartis AG Registered Shares | Healthcare | 11.64 |
Roche Holding AG | Healthcare | 10.49 |
Sanofi SA | Healthcare | 6.55 |
Increase Decrease New since last portfolio | ||
SPDR® MSCI Europe Health Care UCITS ETF | STW |